Recent Updates
Recently added Catalysts
GILD Positive Sentiment

Gilead Sciences to Present at Upcoming March 2026 Investor Conferences

Tuesday, February 24, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Gilead Sciences, Inc. will present at several investor conferences in March 2026. The company's executives will provide insights into their ongoing efforts in advancing innovative medicines. Live webcasts of the presentations will be available on their investor page, with replays accessible for 30 days post-event. Gilead continues to focus on treating life-threatening diseases globally.
Price reaction · baseline $149.83 (2026-02-23 close) · hit pre-market · 3 other GILD headline(s) in the window, move may be shared
day 0 close · peak
-1.5%

Market Sentiment Analysis

POSITIVE FACTORS

  • Gilead Sciences is actively engaging with investors.
  • The company has a long history of medical breakthroughs.
  • Executives will share insights at multiple conferences.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+15%
120-day peak, hindsight
Typical move
1.4%
average across 15 past catalysts
Lead asset
Ranolazine
Phase 2 · Diabetes Mellitus, Type 2

Full Press Release Details

FOSTER CITY, Calif.--(BUSINESS WIRE)--#GILD--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its executives will be speaking at the following investor conferences:
The live webcasts can be accessed at the company’s investors page atinvestors.gilead.com. The replays will be available for at least 30 days following the presentation.
About Gilead Sciences
Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.
For more information on Gilead Sciences, please visit the company’s website atwww.gilead.com, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.

Frequently Asked Questions

When will Gilead Sciences present at investor conferences?

Gilead Sciences will present at investor conferences in March 2026.

How can I access the Gilead investor presentations?

The live webcasts can be accessed on Gilead's investors page.

What is Gilead Sciences known for?

Gilead Sciences is known for breakthroughs in treating life-threatening diseases.

Where is Gilead Sciences headquartered?

Gilead Sciences is headquartered in Foster City, California.

ShareAdd on Google
Tags: GILD Viatris Investor Conferences Healthcare Gilead Sciences investor conferences biopharmaceuticals medical breakthroughs
Last updated: Feb 24, 2026

Biotech snapshot

Cash runway
$3179M liquidity · $0M/mo burn
Low dilution risk
Lead asset
RanolazinePhase 2
Diabetes Mellitus, Type 2 →

Catalyst track record

+15%
best trade around GILD's most recent catalyst

Peak hindsight return over a 120-day window, across 15 tracked FDA/PDUFA catalysts for GILD.

See every catalyst's timing & PoA →